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Role of Rosuvastatin Pretreatment in Prevention of Contrast Induced
Nephropathy in Patients Undergoing Coronary Angiography
Mohsen Fahmy, Ahmed Eltahawy
Ainshams University, Cairo, Egypt
Background: A lot of prospective and retrospective studies focused on statin therapy
as a speciﬁc prophylactic measure of contrast-induced nephropathy. Although these
trials studied the role of different types of statins (atorvastatin, simvastatin and pra-
vastatin) in prevention of contrastinduced nephropathy, few studies tested the role of
rosuvastatin. In this current study, the aim was to assess the efﬁcacy of short-term
high-dose rosuvastatin pretreatment therapy for the prevention of contrast induced
nephropathy.
Methods: This study prospectively included two hundred patients who underwent
coronary angiography, and were randomized into two groups: control group (included
100 patients who did not receive statin therapy) and statin group (included 100 pa-
tients who received rosuvastatin 20 mg/day 3 days before and 7 days after coronary
angiography). According to recommendations of the National kidney foundation,
results had been recorded using both serum creatinine and glomular ﬁlteration rate
levels.
Results: There was statistically signiﬁcant reduction in the incidence of contrast-
induced nephropathy in rosuvastatin pretreated patients (“22%” and “15%” of them
developed contrast-induced nephropathy regarding the glomular ﬁlteration rate and
serum creatinine levels respectively), compared to those in the control group (“35%”
and “38%” regarding the glomular ﬁlteration rate and serum creatinine levels
respectively) with P value (<0.001 regarding serum creatinine and <0.042 regarding
glomular ﬁlteration rate).
Conclusion: Although the results of some clinical studies to prevent contrast-induced
nephropathy using statin pretreatment are conﬂicting, the current study coincided with
several clinical studies in favoring statin pretreatment for preventing contrast induced
nephropathy in patients undergoing coronary angiography. R
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SBifurcation and Left Main Stenting
(TCTAP A-038 to TCTAP A-047)
TCTAP A-038
Promising Results of Stent Boost Assisted Modiﬁed Minicrush Technique for
Treating Bifurcation Lesions
Vithala Surya Prakasa Rao1, Dnyanoba Rambhau2
1Apollo hospital, Hyderabad, India, 2Wockhardt Hospital, Nagpur, India
Background: How Large, How much Important and the Disease Status of the Side
Branch (SB).
Methods: Total 50 patients were studied with a one year follow-up. The Stenting was
done by using modiﬁed Minicrush bifurcation technique assisted by stent boost.
Technique: Side branch (SB) stent positioned 2mm into main branch (MB), with MB
balloon centering the carina of SB. The SB stent (DES) dilated at nominal pressure,
check injection given to look for dissection distal edge of SB stent. The ﬂoppy wire
and balloon removed from the SB, then in MB - dilation given with NC balloon at
14 atm. Then MB (DES) of approximate size is deployed at nominal pressures .The
projection of SB stent in to MB is checked by stent boost. SB is re crossed with a
ﬂoppy wire from the distal cell of stent strut. The serial balloon dilatation with up
sizing balloon was given at the SB Ostial to expand the struts. A sequential kissing
balloon dilatation was also given with non compliant (NC) balloons of suitable size at
14 atms and simultaneous ﬁnal kissing done at 10 atms. A stent boost done with
kissing balloon in place. Check injections given to check stent apposition and TIMI III
ﬂow.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/ORAResults:Conclusion: The stent boost assisted modiﬁed Minicrush technique, study of 50
patients with one year follow up we observed no incidence of acute vessel closure or
stent thrombosis. The 6% percent of these patients were required repeat revasculari-
zation at one year follow up. Stent boost is a cost effective tool to visualize exact SB
stent strut position at places where other imaging modalities IVUS, OCT are un-
available. Thus the stent boost assisted Minicrush technique looks to be promising,
easy to adapt for treating bifurcation lesions.
TCTAP A-039
Could Novel Bio-SYNTAX Score Predict Mortality in Patients Undergoing
Percutaneous Coronary Intervention with Left Main Coronary Artery
Bifurcation Lesions?
Jae Hee Kim, Jang Hoon Lee, Se Yong Jang, Sun Hee Park, Myung Hwan Bae,
Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Shung Chull Chae
Kyungpook National University Hospital, Daegu, Korea (Republic of)
Background: Several studies reported that clinical SYNTAX (Synergy between
Percutaneous Coronary Intervention (PCI) with TAXUS and Cardiac Surgery) score
(CSS) could provide prognostic information in addition to original SS. However,
limited data is available about the prognostic value of N-terminal pro-B type natriuretic
peptide (NT-proBNP) in patients with left main (LM) coronary artery bifurcation
lesions. The aim of this study is to assess whether Bio-CSS would improve the ability
to predict mortality compared with CSS in patients undergoing unprotected LM PCI.
Methods: Between June 2006 and December 2012, 225 patients (170 men; mean age
¼ 65.210.9 year-old) underwent unprotected LM stenting were analyzed in this
study. CSS was calculated by multiplying the SS to an ACEF score (age/left ven-
tricular ejection fraction + 1 if serum creatinine >2mg/dL). Bio-CSS was calculated
by multiplying NT-proBNP score (1 for <100 pg/mL, 2 for 100 - <1000 pg/mL, 3 forL/Basic Science, Animal Models and Preclinical Studies S11
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19th CardioVascular Summit: TCTAP 20141000 – 10,000 pg/mL, and 4 for  10,000 pg/mL) to ACEF score. The mean follow-
up duration was 948642 days.
Results: During the follow-up, 15 (6.7%) deaths occurred. Log-transformed NT-
proBNP level was signiﬁcantly higher in patient with death (5.661.63 versus
8.282.20, p <0.001). Log-transformed NT-proBNP was signiﬁcantly correlated with
SS (r¼0.195, p¼0.003) and CSS (r¼0.647, p<0.001). Bio-CSS (78.378.0 versus
271.5149.9, p <0.001) as well as SS (25.47.0 versus 29.44.80, p¼0.034) and
CSS (42.439.1 versus 123.273.5, p¼0.001) was signiﬁcantly higher in patients
with mortality. In Cox proportional hazards model, Bio-CSS was an independent
predictor of 12-month mortality (HR 1.008, 95% CI 1.004 – 1.012; p <0.001) after
adjusting for conventional clinical risk factors. In receiver operating characteristics
curves, area under the curve (AUC) of Bio-CSS was signiﬁcantly higher compared
with those of SS (0.877 versus 0.709, p ¼0.023) and CSS (0.877 versus 0.853,
p ¼0.047). The optimum cut-off value of Bio-CSS was 150.4 with sensitivity of
80.0% and speciﬁcity of 89.0%. The patients with higher Bio-CSS (>150.4) had a
signiﬁcant higher mortality (34.3% versus 1.6%, p <0.001).
Conclusion: In patients underwent unprotected LM PCI, novel combined scores so-
called Bio-CSS improve the discrimination accuracy of established combined score such
as SS and CSS. Our ﬁnding suggests that biomarker levels in addition to clinical and
angiographic ﬁndings could provide useful prognostic information in these patients.
TCTAP A-040
Treatment of Bifurcation Lesions with Novel Drug Eluting Self-expandable Stent
Axxess: Single Centre First Experience
Farhat Fouladvand, Camillo Falcone, Antonio Mantovani
Holy Family Hospital (Ospedale Sacra Famiglia) Hospitaller Order of St. John of
God, Erba, Italy
Background: The Axxess stent belongs to the category of dedicated bifurcation lesion
stents. It is a self-expanding DES, deployed at the level of the carina. The rationale
behind this stent is to provide an anatomically tailored treatment for the bifurcation with
maximum drug coverage and minimum overlap and deformation of the stent struts.
Our intention was to share our ﬁrst experience with the self expandable drug eluting
bifurcation stent Axxess. We aim to report procedural and in-patient outcomes of this
stent in patients undergoing treatment to bifurcation coronary lesions in a real-world
setting.
Methods:Weanalysed 20 patients treatedwithAxxess stent for bifurcation lesions from
September 2011 to September 2012. From them 17 (85%) were males, mean age 66.
Results: Procedural success was achieved in all 20 (100%) patients. Optimal Axxess
placement was reached in 18 (90%) patients - in one patients the device was placed
after the bifurcation in the main branch and thus procedure was successfully ended
with two additional stents, one in the main branch in overlapping with the Axxess
stent and second DES at side branch as standard provisional T stenting (Fig.1). In the
second case the device landed just prior the bifurcation. In this case we placed other
two DES in main and side branch in overlapping with the Axxess stent. Intra-
procedural complication was seen in only one patient (instent thrombosis) resolved
with adjunctions of IIb/IIIa inhibitors and balloon inﬂation. Femoral access was used
in 12 (60%), predominantly during the ﬁrst cases and the radial in 8 (40%) using
sheathless catheter. Mean Rx time was 26,9.
Conclusion: Our ﬁrst experience with this novel bifurcation stent demonstrated its
high success procedural and device rate. Moreover in case of not optimal placement
the stent behaves as a normal DES and the procedure can be shifted without difﬁ-
culties to classic two stent technic. Our experience also shows that the Axxess stent
can be easily placed using radial approach adopting the sheathless catheter.
TCTAP A-041
Angiographic Result of T-stenting with Small Protrusion Using Drug-eluting
Stents in the Management of Ischemic Side Branch: The ARTEMIS Study
Man-Hong Jim1, Eugene Brian Wu2, Raymond Chi-Yan Fung1, Andrew Kei-Yan Ng1,
Chung-Wah Siu3
1GranthamHospital, Hong Kong, Hong Kong, China, 2Prince of Wales Hospital, Hong
Kong, Hong Kong, China, 3Queen Mary Hospital, Hong Kong, Hong Kong, China
Background: The aim of this study was to examine the mid-term angiographic result
of T-stenting with small protrusion (TAP) as the bailout strategy for treating coronary
bifurcation lesions.
Methods: From 2009 to 2012, symptomatic patients who had severe coronary
bifurcation stenoses were treated one-stent strategy using drug-eluting stents, with
kissing balloon inﬂation whenever side branch impingement occurred. TAP was
performed if either residual diameter stenosis 75%, type B or above dissection, or
ﬂow impairment was observed at the side branch. Restudy angiographic studies were
performed for medium term luminal assessment.
Results: There were 71 patients recruited who had a mean age of 61  12 years, with
male predominance (83%). MEDINA classiﬁcation 1,1,1 lesions were found in over
60% of patients. Themean stent size and length inmain vessel and side branchwere 2.86
 0.43mm and 30  12mmm, and 2.45  0.26mm and 16  6mmm, respectively.
Restudy angiography was performed on 64 (90%) patients at 9.2  3.9 months.
Angiographic restenosis was observed in 8 (12.5%) patients; the late lumen loss in main
vessel and side branch were 0.22  0.19mm and 0.34  0.37mm, respectively.
Conclusion: The use of TAP as the bailout technique for treating coronary bifurcation
lesions is associated with good angiographic outcomes, in terms of late lumen loss and
restenosis, at 9 months.S12 JACC Vol 63/12/Suppl S j April 22–2TCTAP A-042
Immediate & Intermediate Follow Up of Percutaneous Treatment of Bifurcation
Lesion Using Drug Eluting Stent for Main Branch and Drug Eluting Balloon for
the Side Branch, Inbifurcational Coronanary Artery Disease
Saad Al Kasab, Menwar Mutared Al Anazi, Rida Mustafa Nourallah,
Mohamed Al Kasab, Ali Al Masood
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Background: The use of theDES formain branch in bifurcational coronary artery lesion
or using DES main branch with regular balloon for the side branch did not show sig-
niﬁcant improvement at 6/12 follow up particularly for the side branch which still show
signiﬁcant rate restenosis. In bifurcation lesion with signiﬁcant stenosis of both
branches, the restenosis of side branch in high with either provisional or two stent
techniques (15%).
Methods: This registry enrolled 40 patients with coronary artery bifurcation lesion
LAD/diagonal 28 patients, circumﬂes/obtuse marginal branch 8 patients with right
coronary artery/ posterial descending, posterial lateral 4 patients received PCI with
Paclitaxel-eluting balloon for the side branch and DES for main branch. Coronary
angiogram at 6 months follow up achieved in 50%, a nuclear image was performed in
35% and 15% were following up clinically. The mean age group 60.
Results: Procedure success was achieved to all patients the Pre PCI diameter stenosis
was 85.
Conclusion: This small study showed that this technique using DES for the main
branch and DEB for the side branch is safe and effective at immediate and 6-12
months follow up with two patient restenosis and no acute and sub acute coronary
artery thombosis. to our knowledge this study is reported for the ﬁrst time.
TCTAP A-043
Comparison of First versus Second Generation Drug-eluting Stents in
Unprotected Left Main Coronary Artery Intervention
Akkala Raghavender Goud, Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi,
Yoonjee Park, Hu Li, Sunki Lee, Ji Bak Kim, Sung Il Im, Jin Oh Na, Cheol Ung Choi,
Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo,
Dong Joo Oh
Korea University Guro Hospital, Seoul, Korea (Republic of)
Background: Although there are data comparing the individual drug-eluting stents
(DES) in unprotected left main coronary artery (ULMCA) percutaneous coronary
intervention (PCI), there is lack of data in overall comparison of ﬁrst versus second
generation DESs. In this present study we are intended to compare the ﬁrst and second
generation DESs in PCI for ULMCA.
Methods: A total 276 consecutive patients (pts) underwent PCI for ULMCA with
DESs were enrolled for this study. Patients who received BMS (n¼7) were excluded
from the study. Study population was classiﬁed as two groups; Patients who
received ﬁrst generation DESs (n¼189) and second generation DESs (n¼87). We
analysed 6 months angiographic and 1 year clinical outcomes between the two
groups.
Results: Baseline clinical characteristics were comparable between the two groups.
There was no signiﬁcant difference in 6 month angiographic outcomes including
follow up minimum luminal diameter (MLD), diameter stenosis (DS) and late lumen
loss (LL) (p>0.05, Table 1) and 1 year clinical outcomes including mortality, repeat
revascularization, stent thrombosis and major adverse cardiac events (MACE) be-
tween the two groups (p>0.05, Table 2).
Conclusion: In PCI for ULMCA, ﬁrst generation and second generation DESs were
comparable regarding 6-month angiographic and 1-year clinical outcomes in a series
of Asian population.5, 2014 j TCTAP Abstracts/ORAL/Bifurcation and Left Main Stenting
